Lag Time, Scope Of Securities Class Actions Grow

Law360, New York (May 19, 2010, 7:32 PM EDT) -- Companies outside the financial sector may have thought they escaped securities class actions after announcing disappointing earnings. But the reprieve may well have been temporary, with a growing number of securities class actions hitting the docket long after the end of their proposed class periods.

One recent example is a securities class action filed against pharmaceuticals giant Pfizer Inc. alleging it failed to tell investors it was illegally promoting off-label uses for the anti-inflammatory drug Bextra and three other drugs and offering kickbacks to doctors to...
To view the full article, register now.